Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloStim + Cryoablation in mCRC
NCT01741038Phase 3Withdrawn
- Sponsor
- Mirror Biologics, Inc.
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 3 trial of allostim in colorectal cancer (CRC), sponsored by Mirror Biologics, Inc.. Planned start Dec 2017; status: withdrawn.
02
Drugs
allostim
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01741038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741038.